Talphera, Inc. (TLPH)

NasdaqGM - NasdaqGM Delayed Price. Currency in USD

Add to watchlist

0.9256

-0.1144

(-11.00%)

At close: 04:00PM EDT

0.9391

+0.01

(+1.46%)

After hours:

07:23PM EDT

Loading interactive chart...

PR Newswire
Talphera to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced that management will participate in the H.C. Wainwright 26th Annual Global Investment Conference and will be taking 1x1 meetings.
PR Newswire
Talphera Announces First Patient Enrolled in the Registrational Trial Evaluating Nafamostat for Anticoagulation of the Extracorporeal Circuit
Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced the first patient has been enrolled in the NEPHRO CRRT study.
Simply Wall St.
Talphera First Half 2024 Earnings: US$0.31 loss per share (vs US$0.40 loss in 1H 2023)
Talphera ( NASDAQ:TLPH ) First Half 2024 Results Key Financial Results Net loss: US$7.78m (loss widened by 78% from 1H...